nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

01.12.2011 | Original Article

Coagulation and prothrombotic state parameters: a clinical analysis during early pregnancy

verfasst von: H. Chen, L. Zhou, L. Meng, M. Liu, J. Tan, L. Gao, J. Zhang

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Aim

The aim of this study is to assess the changes in coagulation, thrombosis, anticoagulation, and fibrinolysis during early pregnancy.

Methods

One hundred and five pregnant women with monozygotic pregnancies between 10 and 12 weeks gestation were randomly enrolled as the study group, and another 82 non-pregnant women were selected as the control group. Coagulation parameters and prothrombotic state parameters were measured.

Results

Fg, F1 + 2, thrombin–antithrombin complex, GMP140, D-dimer, and plasminogen activator inhibitor 2 were statistically different between the study and the control groups (p < 0.008). The coagulation, fibrinolytic, and the antifibrinolytic functions of healthy pregnant women are enhanced during early pregnancy, whereas the anticoagulation is slightly increased.

Conclusion

Coagulation, fibrinolysis, and antifibrinolysis remain at high levels, whereas the platelet activation remains at low levels during early pregnancy.

Facchinetti F, Marozio L, Frusca T et al (2009) Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 200:46.e1–46.e5. doi:10.1016/j.ajog.2008.07.032 CrossRef

Benedetto C, Marozio L, Tavella AM et al (2010) Coagulation disorders in pregnancy: acquired and inherited thrombophilias. Ann N Y Acad Sci 1205:106–117. doi:10.1111/j.1749-6632.2010.05674.x PubMedCrossRef

Pabinger I (2009) Thrombophilia and its impact on pregnancy. Thromb Res 123:S16–S21. doi:10.1016/S0049-3848(09)70128-8 PubMedCrossRef

Rousseau A, Favier R, Van Dreden P (2009) Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Europ J Obstet Gynecol Reprod Biol 146:46–49. doi:10.1016/j.ejogrb.2009.06.001 CrossRef

Ismail SK, Higgins JR (2011) Hemostasis in pre-eclampsia. Semin Thromb Hemost 37:111–117. doi:10.1055/s-0030-1270336 PubMedCrossRef

Kovac M, Mikovic Z, Rakicevic L et al (2010) The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy. Europ J Obstet Gynecol Reprod Biol 148:27–30. doi:10.1016/j.ejogrb.2009.09.005 CrossRef

Lobov S, Croucher DR, Saunders DN et al (2008) Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions. Thromb Haemost 100:319–329 pii: 08080319PubMed

Liu XH, Jiang YM, Shi H et al (2008) Prospective, sequential, longitudinal study of coagulation changes during pregnancy in Chinese women. Int J Gynaecol Obstet 105:240–243. doi:10.1016/j.ijgo.2009.01.035 CrossRef

Cerneca F, Ricci G, Simeone R et al (1997) Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Europ J Obstet Gynecol Reprod Biol 73:31–36. doi:10.1016/S0301-2115(97)02734-6 CrossRef

10.

Pierangeli SS, Leader B, Barilaro G et al (2011) Acquired and inherited thrombophilia disorders in pregnancy. Obstet Gynecol Clin North Am 38:271–295. doi:10.1016/j.ogc.2011.02.016 PubMedCrossRef

11.

Facchinetti F, Marozio L, Grandone E et al (2003) Thrombophilic mutations are a main risk factor for placental abruption. Haematologica 88:785–788PubMed

12.

Chavarría ME, Lara-González L, González-Gleason A et al (2003) Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia. Am J Obstet Gynecol 188:986–992. doi:10.1067/mob.2003.203 PubMedCrossRef

13.

Paniccia R, Prisco D, Bandinelli B et al (2002) Plasma and serum levels of D dimer and their correlations with other hemostatic parameters in pregnancy. Thromb Res 105:257–262. doi:10.1016/S0049-3848(02)00022-1 PubMedCrossRef

14.

Schlembach D, Beinder E, Zingsem J et al (2003) Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction. Clin Sci 105:279–285. doi:10.1042/CS20030073 PubMedCrossRef

15.

Zhao S, Gu Y, Lewis DF, Wang Y (2008) Predominant basal directional release of thromboxane, but not prostacyclin, by placental trophoblasts from normal and preeclamptic pregnancies. Placenta 29:81–88. doi:10.1016/j.placenta.2007.08.007 PubMedCrossRef

16.

Bowen RS, Zhang Y, Gu Y et al (2005) Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition. Placenta 26:402–409. doi:10.1016/j.placenta.2004.07.007 PubMedCrossRef

17.

Mills JL, DerSimonian R, Raymond E et al (1999) Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA 282:356–362. doi:10.1001/jama.282.4.356 PubMedCrossRef

18.

19.

Al Kadi H, Nasrat H, Broughton Pipkin F (2005) A prospective, longitudinal study of the rennin-angiotensin system, prostacyclin and thromboxane in the first trimester of normal human pregnancy: association with birth weight. Hum Reprod 20:3157–3162. doi:10.1093/humrep/dei184 PubMedCrossRef

20.

Shi Q, Chen C, Wang XF et al (2004) Clinical study of hemostatic coagulation markers in prethrombosis state of pregnancy induced hypertension. Zhong hua Fu Chan Ke Za Zhi 39:733–736

21.

Eichinger S (2005) Dimer testing in pregnancy. Semin Vasc Med 5:375–378. doi:10.1055/s-2005-922483 PubMedCrossRef

22.

Ver Elst K, Jochmans K, De Pauw A et al (2002) Plasma D-dimer concentrations in different clinical conditions. Acta Clin Belg 57:325–330PubMed

23.

Chan WS, Lee A, Spencer FA et al (2010) D-dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis. J Thromb Haemost 8:1004–1011. doi:10.1111/j.1538-7836.2010.03783.x PubMedCrossRef

24.

Kabrhel C, Mark Courtney D, Camargo CA Jr et al (2010) Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism. Acad Emerg Med 17:589–597. doi:10.1111/j.1553-2712.2010.00765.x PubMedCrossRef

25.

Portelinha A, Cerdeira AS, Belo L et al (2009) Haemostatic factors in women with history of preeclampsia. Thromb Res 124:52–56. doi:10.1016/j.thromres.2008.10.005 PubMedCrossRef

26.

Francalanci I, Comeglio P, Alessandrello Liotta A et al (1997) D-dimer plasma levels during normal pregnancy measured by specific ELISA. Int J Clin Lab Res 27:65–67. doi:10.1007/BF02827245 PubMedCrossRef

27.

Chabloz P, Reber G, Boehlen F et al (2001) TAFI antigen and D-dimer levels during normal pregnancy and at delivery. Br J Haematol 115:150–152. doi:10.1046/j.1365-2141.2001.03082.x PubMedCrossRef

28.

Buduneli N, Becerik S, Buduneli E et al (2010) Gingival status, crevicular fluid tissue-type plasminogen activator, plasminogen activator inhibitor-2 levels in pregnancy versus post-partum. Aust Dent J 55:292–297. doi:10.1111/j.1834-7819.2010.01237.x PubMedCrossRef

29.

Wikström AK, Nash P, Eriksson UJ et al (2009) Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia. Am J Obstet Gyneco 201:597.e1–597.e8. doi:10.1016/j.ajog.2009.06.024 CrossRef

30.

Tanjung MT, Siddik HD, Hariman H et al (2005) Coagulation and fibrinolysis in preeclampsia and neonates. Clin Appl Thromb Hemost 11:467–473PubMedCrossRef

31.

Hellgren M (2003) Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 29:125–130. doi:10.1055/s-2003-38897 PubMedCrossRef

32.

Chetaille P, Alessi MC, Kouassi D et al (2000) Plasma TAFI antigen variations in healthy subjects. Thromb Haemost 83:902–905PubMed

Titel: Coagulation and prothrombotic state parameters: a clinical analysis during early pregnancy
verfasst von: H. Chen
L. Zhou
L. Meng
M. Liu
J. Tan
L. Gao
J. Zhang
Publikationsdatum: 01.12.2011
Verlag: Springer-Verlag
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 4/2011
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-011-0737-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aim

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

Three synchronous gastrointestinal tumours

Current consequences of “Boolean” intuitions

Pneumothorax and empyema complicating Scedosporium apiospermum mycetoma: not just a problem in the immunocompromised patients

Warfarin anticoagulation: a survey of patients’ knowledge of their treatment

Biomarkers for the differentiation of sepsis and SIRS: the need for the standardisation of diagnostic studies